Merck Presents New Phase 3 Data for Investigationa...
Category : Clinical Trial Update 16 October 2025Merck (known as MSD outside the U.S. and Canada) presented additional results from two Phase 3 clini...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Clover Biopharmaceuticals Reports Positive Early D...
Category : Clinical Trial Update 16 October 2025Clover Biopharmaceuticals, Ltd., a global commercial-stage biotechnology company focused on developi...
Boehringer Ingelheim and Click Therapeutics Report...
Category : Clinical Trial Update 16 October 2025Boehringer Ingelheim and Click Therapeutics presented data from the pivotal phase III CONVOKE study...
CalciMedica and Telperian Collaborate to Apply AI...
Category : Clinical Trial Update 16 October 2025CalciMedica Inc., a clinical-stage biopharmaceutical company developing CRAC channel inhibition ther...
FDA Approves IDE for Avisi Technologies’ VisiPlate...
Category : Approval/Launch 15 October 2025Avisi Technologies, Inc., a clinical-stage ophthalmic medical device company developing sight-saving...
Latest Newsletter Post
-
CalciMedica and Telperian Collabora..
16 October 2025
-
Boehringer Ingelheim and Click Ther..
16 October 2025
-
Clover Biopharmaceuticals Reports P..
16 October 2025
-
Merck Presents New Phase 3 Data for..
16 October 2025
-
Quotient Sciences and Biorasi Partn..
15 October 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com